Local view for "http://purl.org/linkedpolitics/eu/plenary/2001-10-04-Speech-4-192"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2001-10-04"^^xsd:date2
dcterms:Is Part Of	lp_eu:Patenting of human genes2
dcterms:Language	"de"^^xsd:language2
lpv:document identification number	"en.20011004.9.4-192"2
lpv:hasSubsequent	lp_eu:2001-10-04-Speech-4-1932
lpv:speaker	lp:Hiltrud Breyer2
lpv:spokenAs	member; Committee on the Environment, Public Health and Consumer Policy (1999-07-21--2002-01-14)3 substitute; Committee on Legal Affairs and the Internal Market (1999-07-22--2002-01-14)3 substitute; Committee on Women's Rights and Equal Opportunities (1999-07-22--2002-01-14)3 member; Temporary committee on human genetics and other new technologies in modern medicine (2000-12-13--2001-11-29)3 unknown; Bündnis 90/die Grünen (1999-07-20--2004-07-19)3 member; G/EFA (1999-07-20--2004-07-19)3 member; Delegation for relations with the Member States of ASEAN, South-east Asia and the Republic of Korea (1999-09-28--2002-01-14)3
lpv:translated text	"Mr President, I vigorously endorse what Ms Oomen-Ruijten has said. Commissioner, you cannot take an infinite amount of time over this. I too expect that the Commission will state its position on this issue by 9 October. You said that there are no objections of an ethical nature, but that you will study the question of the field of protection for inventions. However, you have not answered the question put to you by myself, Mr Blokland, and others on whether Article 5.1 now applies in this context or whether Article 5.2 should take priority. I believe that many Members of this House expect the Commission to clarify this serious and very important issue."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph